Clinical Trial Update: Aggressive Versus Conservative Blood Glucose Control in Hospitalized Type 2 Diabetic Patients Using Detemir and Aspart Insulin [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing aggressive versus conservative blood glucose control in hospitalized patients with Type 2 diabetes was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• aspart insulin (aspart)
• detemir insulin (detemir)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Type 2 Diabetes | Phase 4 | Status: WITHDRAWN